Literature DB >> 10692533

Intravenous recombinant erythropoietin does not lead to an increase in cerebrospinal fluid erythropoietin concentration.

M Buemi1, A Allegra, F Corica, F Floccari, D D'Avella, C Aloisi, G Calapai, G Iacopino, N Frisina.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10692533     DOI： 10.1093/ndt/15.3.422

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  4 in total

1.  The pharmacokinetics of erythropoietin in the cerebrospinal fluid after intravenous administration of recombinant human erythropoietin.

Authors:  Anargyros Xenocostas; Wing K Cheung; Francis Farrell; Cindy Zakszewski; Marian Kelley; Andrzej Lutynski; Michael Crump; Jeffrey H Lipton; Thomas L Kiss; Catherine Y Lau; Hans A Messner
Journal:  Eur J Clin Pharmacol       Date:  2005-03-18       Impact factor: 2.953

2.  Transfection of primary brain capillary endothelial cells for protein synthesis and secretion of recombinant erythropoietin: a strategy to enable protein delivery to the brain.

Authors:  Annette Burkhart; Thomas Lars Andresen; Achim Aigner; Louiza Bohn Thomsen; Torben Moos
Journal:  Cell Mol Life Sci       Date:  2017-03-14       Impact factor: 9.261

3.  Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury.

Authors:  M L Brines; P Ghezzi; S Keenan; D Agnello; N C de Lanerolle; C Cerami; L M Itri; A Cerami
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

Review 4.  Erythropoietin: powerful protection of ischemic and post-ischemic brain.

Authors:  Anh Q Nguyen; Brandon H Cherry; Gary F Scott; Myoung-Gwi Ryou; Robert T Mallet
Journal:  Exp Biol Med (Maywood)       Date:  2014-03-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.